Previous 10 | Next 10 |
2023-08-16 02:57:08 ET Summary RxSight's Q2 2023 earnings showed an 83% increase in revenue, driven by growth in LDD and LAL earnings. The company has a healthy liquidity position with $147.1M in liquid assets and a reduced term loan liability. Despite ongoing operational loss...
2023-08-07 20:56:08 ET RxSight, Inc. (RXST) Q2 2023 Earnings Call Transcript August 07, 2023 04:30 PM ET Company Participants Alex Huang - Director, IR Ron Kurtz - President and CEO Shelley Thunen - CFO Conference Call Participants Robbie Marcus - JPM...
2023-08-07 16:58:13 ET RxSight press release ( NASDAQ: RXST ): Q2 Non-GAAP EPS of -$0.28 beats by $0.11 . Revenue of $20.8M (+82.5% Y/Y) beats by $1.57M . For further details see: RxSight Non-GAAP EPS of -$0.28 beats by $0.11, revenue of $20.8M beats by $...
ALISO VIEJO, Calif., Aug. 07, 2023 (GLOBE NEWSWIRE) -- RxSight, Inc., an ophthalmic medical device company dedicated to providing high-quality customized vision to patients following cataract surgery, today reported financial results for the three and six months ended June 30, 2023. Key Q...
ALISO VIEJO, Calif., July 25, 2023 (GLOBE NEWSWIRE) -- (NASDAQ: RXST) – RxSight, Inc., an ophthalmic medical device company dedicated to providing high-quality customized vision to patients following cataract surgery, today announced that it will report financial results for the second...
2023-05-16 05:42:55 ET Summary RxSight beat Q1 2023 revenue and EPS estimate and modestly increased the full-year revenue guidance range. However, the improved margin outlook was the most surprising part and the likely reason the stock surged to new highs last week. With Q1 be...
2023-05-13 19:14:09 ET RxSight, Inc. (RXST) Q1 2023 Results Conference Call May 09, 2023 04:30 PM ET Company Participants Alex Huang - Director, IR Ron Kurtz - President and CEO Shelley Thunen - CFO Conference Call Participants Allen Gong - JP Morgan ...
2023-05-10 10:00:34 ET Gainers: CTI BioPharma ( CTIC ) +85% . Cano Health ( CANO ) +29% . TScan Therapeutics ( TCRX ) +24% . RxSight ( RXST ) +11% . Guardant Health ( GH ) +14% . Losers: Babylon Holdings ( BBLN ) -71...
2023-05-09 16:51:15 ET RxSight press release ( NASDAQ: RXST ): Q1 Non-GAAP EPS of -$0.31 beats by $0.14 . Revenue of $17.5M (+96.6% Y/Y) beats by $1.22M . For further details see: RxSight Non-GAAP EPS of -$0.31 beats by $0.14, revenue of $17.5M beats by $...
ALISO VIEJO, Calif., May 09, 2023 (GLOBE NEWSWIRE) -- (NASDAQ: RXST) – RxSight, Inc., an ophthalmic medical device company dedicated to providing high-quality customized vision to patients following cataract surgery, today reported financial results for the three months ended March 31,...
News, Short Squeeze, Breakout and More Instantly...
ALISO VIEJO, Calif., July 22, 2024 (GLOBE NEWSWIRE) -- (NASDAQ: RXST) – RxSight, Inc., an ophthalmic medical device company dedicated to providing high-quality customized vision to patients following cataract surgery, today announced that it will report financial results for the second...
ALISO VIEJO, Calif., June 05, 2024 (GLOBE NEWSWIRE) -- RxSight, Inc., an ophthalmic medical device company dedicated to providing high-quality customized vision to patients following cataract surgery, today announced plans to participate in the upcoming Truist Securities MedTech Conference. ...
Shareholders approved all agenda items and proposals of the Board of Directors Robert K. Warner, M.B.A. and Arshad M. Khanani, M.D., M.A., FASRS elected as members of the Board of Directors Baruch D. Kuppermann, M.D., Ph.D. and Frank G. Holz, M.D., Ph.D. appointed as members of th...